3D Cancer Model Development Services

To this date, numerous developments, like organoids, in 3D culturing technology, have made creating novel, more physiological human cancer models possible. At Alfa Cytology, we focus on developing 3D cancer models and aim to provide researchers and scientists working in oncology with cutting-edge tools. Our services help clients streamline their drug discovery process and further their knowledge of cancer biology.

Overview of 3D Cancer Models

Cancer kills about 10 million people yearly, and with the trend, it certainly will increase. Cancer therapeutics remain scarce; this is partly due to the very few preclinical in vitro models that accurately replicate the diversity in human tumors, which range in morphology, molecular characteristics, and their microenvironment.

Fig.1 Evolution of organoid technology for cancer modeling. (Yan, H. H. N., et al., 2023)

Developments in 3D organoid culture provide a unique approach to bridge the gaps between the 2D cell line in vitro and the mouse model in vivo for cancer research. Such preclinical models are useful and crucial components to help bridge the gap between cancer basic research and its available therapeutics. This has been recognized by major regulatory bodies. For instance, the FDA has shown strong support for alternative models and has begun publishing guiding principles that include the use of organoids, highlighting their potential to revolutionize preclinical research.

Application of Cancer Organoid Models

Cancer organoid models are powerful systems with a range of uses for basic and applied research. These models are integral for the discovery and validation of new drugs, particularly for the more complex and physiologically relevant ones. Researchers use organoids to study the multifaceted interactions of a tumor with its microenvironment, as well as the underlying biology of cancer. Such uses make cancer organoids a crucial component of systems aimed at improving our knowledge of this disease.

Fig.2 Using patient-derived organoids in cancer research. (Kretzschmar K., 2021)

Our Services

Alfa Cytology provides a full suite of services in every stage of your research, with a supporting focus on developing physiologically relevant 3D models of cancer and their functional and molecular detailed characterization services. The aim is to provide researchers with reliable, reproducible models that capture the tumor environment. Such models enable you to expedite the drug discovery process to validate therapeutic targets and elucidate the intricacies of disease pathology.

Cancer Organoid Model Development Services

The development of organoids is customized to match your research and development objectives. Our expertise spans various types of cancer, and we are able to transform complex patient tumor tissues, induced pluripotent stem cells (iPSCs), or cell lines into functional 3D organoid models that accurately capture architecture, microenvironment, and heterogeneity.

Cancer Organoid Model Characterization Services

Obtaining a robust characterization is equally important for validating the biological relevance of your 3D cancer models. We provide characterization services of different types to ensure the quality and integrity of your organoids.

Organoid Model-based Research Services

With our expertise in 3D cancer model development and characterization, we can help you move forward considerably in your research and understanding of cancer biology. Our team stands ready to provide reproducible and high-quality 3D cancer model development services that can be pivotal to your preclinical development and core studies. Would you like to progress your cancer research using tumor physiologically relevant 3D models? Contact us today to discuss your project and learn how we can help.

For research use only.